PDF] Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial US$ 23.22 Min. order: 1 piece ★★★★★ 4.1 (172 reviews) Sold : Login>>
Cagrilintide Combined with Semaglutide: A New Approach for Treatment of Obesity and Type 2 Diabetes US$ 26.02 Min. order: 1 piece ★★★★★ 5.0 (256 reviews) Sold : Login>>
Triple Agonism Based Therapies for Obesity | Current Cardiovascular Risk Reports US$ 23.60 Min. order: 1 piece ★★★★★ 4.3 (87 reviews) Sold : Login>>